Senate Committee Calls For Greater Oversight Of At-Home Genetic Tests
This article was originally published in The Gray Sheet
Executive Summary
A Senate leader prodded FDA and CMS officials to strengthen oversight of genetic tests offered directly to consumers via the internet following the release of a report questioning the validity of some of those tests
You may also be interested in...
Draft Guidance On Lab-Produced Tests Being Misinterpreted – Gutman
Stakeholders have developed "misconceptions" regarding a recent draft guidance published by FDA on certain laboratory-developed assays, says Steve Gutman, director of the CDRH Office of In Vitro Diagnostic Device Evaluation & Safety
Draft Guidance On Lab-Produced Tests Being Misinterpreted – Gutman
Stakeholders have developed "misconceptions" regarding a recent draft guidance published by FDA on certain laboratory-developed assays, says Steve Gutman, director of the CDRH Office of In Vitro Diagnostic Device Evaluation & Safety
Momentum Intensifies To Enhance Oversight Of Lab-Produced Genetic Tests
Calls to beef up regulations impacting genetic tests fashioned by clinical laboratories are getting louder, with particular emphasis on augmenting FDA's oversight role